Home603233 • SHA
add
Dashenlin Pharmaceutical Group Co Ltd
Previous close
¥14.00
Day range
¥13.81 - ¥14.08
Year range
¥11.92 - ¥27.10
Market cap
16.11B CNY
Avg Volume
4.72M
P/E ratio
18.91
Dividend yield
3.30%
Primary exchange
SHA
Market news
Investopedia
3 hours ago
FMC Stock Biggest S&P Decliner With Q4 Net Loss, Sees Lowest Level in 9
Years
33.53%
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 6.39B | 11.42% |
Operating expense | 1.85B | 12.32% |
Net income | 200.53M | -21.95% |
Net profit margin | 3.14 | -29.91% |
Earnings per share | — | — |
EBITDA | 396.50M | -20.26% |
Effective tax rate | 23.51% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.72B | 53.05% |
Total assets | 25.88B | 20.75% |
Total liabilities | 17.75B | 30.92% |
Total equity | 8.13B | — |
Shares outstanding | 1.14B | — |
Price to book | 2.32 | — |
Return on assets | 3.32% | — |
Return on capital | 5.51% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 200.53M | -21.95% |
Cash from operations | 742.17M | -26.07% |
Cash from investing | -388.85M | -22.44% |
Cash from financing | -34.36M | 90.23% |
Net change in cash | 318.96M | -4.66% |
Free cash flow | -350.15M | 23.27% |
About
Founded
Feb 12, 1999
Website
Employees
45,466
